Respiratory Flashcards

(42 cards)

1
Q

Types of lung cancer

A

Small cell vs NSCLC
NSCLC:
- Squamous most common
- Adeno - classically nonsmoker
- Large
Small cell often metastatic at presentation, almost all smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Small cell lung cancer management

A
  • Few surgical options given usually presents with advanced disease
  • Therefore chemo+/-immunotherapy
  • Some evidence for prophylactic cranial irradiation
  • Small cell often produces polypeptide hormones e.g. ACTH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Lung cancer pathology options

A
  • Sputum cytology (very low sens, better w central lesions)
  • VATS
  • Bronchoscopy + direct or EBUS. EBUS better for staging as lesion + nodes can be accessed
  • Transthoracic needle asp.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Lung cancer central vs peripheral lesions

A

Central - squamous, small, large
Peripheral - Adeno

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

eGFR mutation in lung cancer relevance

A
  • Site for targeted TK targeted therapy
  • More likely positive in low/no smoking pts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ECOG performance status

A

Eastern Coop Onc group
0 - Fully active
5 - deceased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

VATS indications

A

Wedge resection (good for benign lesions e.g. aspergillus)
Bullectomy
Lung biopsy
Recurrent PTx
Lobectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

VATS vs thoracotomy scars

A

Thoracotomy:
- Large (15-20cm) lateral chest wall scar
- Possibly drain scar also
VATS
- 3 scars that triangulate
- 3-6cm scar on lateral wall largest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Benefits of VATS over thoracotomy

A

Smaller incision -> reduced healing time, bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Lobectomy indications

A

Lung cancer
Aspergilloma
TB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lobectomy/pneumonectomy workup

A

PFTs inc transfer factor and exercise testing.
FEV1 >1.5L for lobectomy, >2L for pneumonectomy
VO2 max >15ml/kg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Respiratory causes of clubbing

A
  • Lung cancer
  • Chronic suppurative conditions - bronchiectasis, abscess, CF
  • Interstitial lung disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Signs to distinguish lobectomy from pneumonectomy

A

Pneumonectomy:
- trachea deviated
- unilateral reduced expansion
- dull hemothorax
- absent tactile fremitus beneath the scar
- Bronchial breathing in upper zones may be present
Lobectomy:
- Trachea central if old
- Lower - dull lower zone with abs breath sounds
- Upper - Hyper-resonant upper zone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Single lung transplant indications

A

“Dry lung”
- COPD
- Fibrosis

COPD biggest indication for transplant worldwide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Double lung transplant indications

A

“Wet lung”
- CF
- Bronchiectasis
- Pulmonary hypertension
(or ILD/COPD - prognosis better for double lung for all indications)

COPD biggest indication for transplant worldwide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

VATS indications resp

A
  • Lung resection (wedge/lobe/segment)
  • Bullectomy
  • Pleural drainage/pleurodesis
  • Diagnostic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

PTx management

A

Asymptomatic - nothing
High risk features - chest drain if >2cm
Symptomatic, no HRF, sufficient size - aspirate, drain or conservative

Persistent >24-48h? Recurrent? Consider pleurodesis/pleurectomy

18
Q

PTx high risk features

A
  • Sig desat
  • HD instab
  • Bilat
  • Underlying lung disease
  • Haemoptx
19
Q

Asthma chronic management

A

1- AIR therapy - anti-inflammatory reliever (formoterol/ICS) PRN
2 - MART - same inhaler regular
3 - MART higher dose
4 - Ref to specialist or LTRA (montelukast) or LAMA (e.g. tiotropium)

20
Q

Role of FeNO in asthma diagnosis

A
  • FeNO = Fraction exhaled nitric oxide
  • NO in parts per billion
  • Raised NO demonstrates airway inflammation as inflammatory cytokines induce NO synthase. NO has a role in negative feedback of bronchoconstriction
  • > 50ppb supportive of asthma dx
21
Q

Asthma investigation

A

(Progress if each step normal)
1 - Eosinophils or FeNO
2 - Spirometry (FEV1:FVC<0.7) with reversibility
3 - PEFR diary with variability (>20%)
4 - Bronchial challenge

22
Q

BTS asthma spirometry results

A
  • Reversibility PEFR 12% and FEV1 200ml more than baseline
23
Q

Basal pulmonary fibrosis causes

A
  • ILD
  • Asbestosis
  • Connective tissue diseases (RA, scleroderma, systemic sclerosis, IBD)
  • Drugs - bleomycin, nitrofurantoin, amiodarone. (MTX now considered unlikely to cause fibrosis)
  • Chronic aspiration
24
Q

Apical pulmonary fibrosis causes

A
  • TB
  • Hypersensitivity pneumonitis aka extrinsic allergic alveolitis (e.g. birds) / ABPA late stage
  • Coal miners pneumoconiosis -> progresses to progressive massive fibrosis
  • Silicosis -> progressive massive fibrosis
  • Ank spond
  • Sarcoidosis
25
Pulmonary fibrosis causative drugs
- Nitrofurantoin - Bleomycin - Amiodarone - Sulfasalazine
26
Fibrosis PFTs
- Reduced FEV1, Reduced FVC, preserved FEV1/FVC (>0.8) - Reduced transfer factor (TLCO, KCO)
27
IPF management
- Nintedanib / pirfenidone if PVC <80% - antifibrotics - Lifestyle - stop smoking - Consider referral for transplant - ACP - median survival 2-5 years + Supportive: - Symptom management - Oxygen - Treat exacerbations - PT/OT/resp CNS
28
IPF investigations
Bedside: - PFTs - ABG (T1RF, T2 in end stage) - Obs Bloods: - CRP, ESR - ANA & RF positive in some - anti-CCP and myositis panel suggestive of alternative to IPF Imaging: - CXR - HRCT most important Special: - Consider BAL/biopsy if unclear diagnosis
29
What is NSIP
Non specific interstitial pneumonia - Idiopathic interstitial lung disease - Predominant ground glass > honeycombing on CT - Therefore more responsive to antiinflammatories - steroids, then DMARDs e.g. MMF
30
What is cryptogenic organising pneumonia
ILD affecting peripheral alveoli/bronchioles Often caused by drugs, infection, RA Pred usually used to treat
31
Causes of EAA/HP
Microorganisms: - Actinomycetes (bacteria)- farmer's lung - Aspergillus (this is not ABPA) Animal proteins: - Bird fancier's lung - Large farm animals Occupational: - Metalworking fluid - Epoxy resins - Spray paints Presents with fevers/chills as well as resp symptoms. Not IgE so not wheezy
32
ILD lung transplant indications
Refer for consideration when: UIP/IPF & fibrotic forms of NSIP should be referred regardless of lung function (i.e. at diagnosis) if fit enough. Others referred when FVC<80% or O2 req
33
Cystic fibrosis genetics
CFTR gene (cystic fibrosis transmembrane conductance regulator). Autosomal recessive. Most common = delta F508 gene
34
Cystic fibrosis important bacteria
- Pseudomonas most common in adults - (S aureus in childhood) - Burkholderia & mycobacterium abscessus contraindication to transplant, and poor prognostic indicator
35
Extrapulmonary cystic fibrosis
- Pancreatic insufficiency -> poor absorption fat soluble vitamins, diabetes - Chronic liver disease - Hypersplenism - Osteoporosis and fractures - Gall stones - Kidney stones - Subfertility. Absence vas deferens in males - Constipation and distal intestinal obstruction syndrome
36
CF most common presentation
- Screening on heel prick in infancy - Followed by genetic testing & sweat test
37
CF medical therapies
Respiratory: - Nebulised Abx - Prophylactic Abx - Nebulised hypertonic saline and mucolytics (DNase) - CFTR modulators - e.g. ivacaftor, often in combination e.g. Trikafta
38
Leading cause of death post lung transplant
Bronchiolitis obliterans - chronic rejection. Usually terminal event. 20% 1 year mortality.
39
Lung transplant immunosuppression
- Tacrolimus - MMF - Steroids in combination
40
Lung transplant contraindications
Loads! - Recent malignancy <5y - Poor PS / comorbidities - Certain infections e.g. Burkholderia and Mycobacterium abscessus - Smoking - BMI >35 or <17 - Poor treatment adherence
41
Transudate vs exudate effusion
Protein <25g/L = transudate, >35g/L = exudate Between - lights criteria: - Pleural/serum protein >0.5 - Pleural/serum LDH >0.6 - Pleural LDH >2/3 ULN serum LDH Any one = exudative
42
Empyema effusion findings
- pH <7.2 - Frank pus